• Intellia Therapeutics (NASDAQ:NTLA) Price Target Cut to $55.00 by Analysts at Barclays

    Source: Buzz FX / 08 Nov 2024 13:01:17   America/Chicago


    Intellia Therapeutics (NASDAQ:NTLA) Price Target Cut to $55.00 by Analysts at Barclays Written by MarketBeat November 8, 2024 Share Link copied to clipboard. Intellia Therapeutics ( NASDAQ:NTLA - Get Free Report ) had its price objective cu
    Read more...
Share on,